IntegraFin Holdings PLC (GB:IHP)
LSE:IHP

IntegraFin Holdings PLC (IHP) Income Statement

2 Followers

IntegraFin Holdings PLC Income Statement

Last quarter (Q4 2022), IntegraFin Holdings PLC's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, IntegraFin Holdings PLC's net income was £―. See IntegraFin Holdings PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
-£ 133.60M£ 123.67M£ 107.32M£ 99.17M£ 91.19M
Cost of Revenue
-£ 2.10M£ 42.51M£ 37.60M£ 36.90M£ 35.11M
Gross Profit
-£ 131.50M£ 81.16M£ 69.72M£ 62.27M£ 56.09M
Operating Expense
-£ 271.80M£ -17.30M£ 14.78M£ 3.83M£ 10.06M
Operating Income
-£ -140.30M£ 98.46M£ 54.95M£ 58.44M£ 46.03M
Net Non Operating Interest Income Expense
-£ -100.00K£ 204.18M£ -137.43M£ -125.22M£ 211.00K
Other Income Expense
-£ -194.70M----
Pretax Income
-£ 54.30M£ 94.65M£ 52.26M£ 57.03M£ 46.23M
Tax Provision
-£ 10.30M£ 43.54M£ 6.77M£ 15.92M£ 13.32M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ 44.00M£ 51.11M£ 45.48M£ 41.11M£ 32.91M
Basic EPS
-£ 0.13£ 0.15£ 0.14£ 0.12£ 0.10
Diluted EPS
-£ 0.13£ 0.15£ 0.14£ 0.12£ 0.10
Basic Average Shares
-£ 330.90M£ 331.00M£ 331.20M£ 331.30M£ 331.30M
Diluted Average Shares
-£ 331.30M£ 331.30M£ 331.30M£ 331.30M£ 331.30M
Dividend Per Share
-£ 0.10£ 0.09£ 0.08£ 0.09-
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----£ 0.12£ 0.11
Reported Normalized Diluted E P S
----£ 0.12£ 0.11
Rent Expense Supplemental
---£ 7.00K£ 3.64M£ 3.63M
Total Expenses
-£ 273.90M£ -25.21M£ 52.38M£ 40.73M£ 45.17M
Net Income From Continuing And Discontinued Operation
-£ 44.00M£ 51.11M£ 45.48M£ 41.11M£ 32.91M
Normalized Income
-£ 44.08M£ 76.89M£ 37.63M£ 48.24M£ 32.93M
Interest Expense
---£ 233.00K£ 0.00-
EBIT
-£ 55.20M£ 94.81M£ 52.49M£ 57.03M£ 46.03M
EBITDA
-£ 58.20M£ 94.81M£ 55.06M£ 57.70M£ 46.64M
Currency in GBP

IntegraFin Holdings PLC Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis